- Home
- GCMGW vs MRK Comparison
GCMGW vs MRK Comparison
Compare GCMGW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMGW
- MRK
- Stock Information
- Founded
- GCMGW 1971
- MRK 2000
- Country
- GCMGW United States
- MRK United States
- Employees
- GCMGW 549
- MRK N/A
- Industry
- GCMGW Finance/Investors Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- GCMGW Finance
- MRK Health Care
- Exchange
- GCMGW Nasdaq
- MRK Nasdaq
- Market Cap
- GCMGW N/A
- MRK 198.5B
- IPO Year
- GCMGW N/A
- MRK N/A
- Fundamental
- Price
- GCMGW $0.64
- MRK $79.11
- Analyst Decision
- GCMGW
- MRK Buy
- Analyst Count
- GCMGW 0
- MRK 15
- Target Price
- GCMGW N/A
- MRK $113.71
- AVG Volume (30 Days)
- GCMGW 62.4K
- MRK 17.5M
- Earning Date
- GCMGW 02-13-2025
- MRK 07-29-2025
- Dividend Yield
- GCMGW N/A
- MRK 4.09%
- EPS Growth
- GCMGW N/A
- MRK 667.14
- EPS
- GCMGW 0.03
- MRK 6.88
- Revenue
- GCMGW $514,011,999.00
- MRK $63,922,000,000.00
- Revenue This Year
- GCMGW N/A
- MRK $2.42
- Revenue Next Year
- GCMGW N/A
- MRK $5.77
- P/E Ratio
- GCMGW $33.02
- MRK $11.51
- Revenue Growth
- GCMGW 15.79
- MRK 4.10
- 52 Week Low
- GCMGW $2.28
- MRK $73.31
- 52 Week High
- GCMGW $2.50
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- GCMGW N/A
- MRK 49.11
- Support Level
- GCMGW N/A
- MRK $78.14
- Resistance Level
- GCMGW N/A
- MRK $80.25
- Average True Range (ATR)
- GCMGW 0.00
- MRK 1.77
- MACD
- GCMGW 0.00
- MRK -0.05
- Stochastic Oscillator
- GCMGW 0.00
- MRK 37.66
About GCMGW GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.